Transplantation and Damage-Associated Molecular Patterns (DAMPs)

American Journal of Transplantation

Volumn 16, Issue 12, 2016, Pages 3338-3361

  Land, W G ^a,b   Agostinis, P ^c   Gasser, S ^d   Garg, A D ^c   Linkermann, A ^e,f  

^a German Academy of Transplantation Medicine   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e Inflammation at Interfaces ^*  (Germany)

^f UNIVERSITY OF KIEL   (Germany)

Author keywords

basic (laboratory) research science; cell death; cellular biology; immunobiology; molecular biology; rejection; tissue injury and repair; translational research science

Indexed keywords

BIOLOGICAL FACTOR; DAMAGE ASSOCIATED MOLECULAR PATTERN; INFLAMMASOME; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

CELL DEATH; DNA DAMAGE; DNA DAMAGE RESPONSE; ENDOPLASMIC RETICULUM STRESS; HEAT SHOCK RESPONSE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; REPERFUSION INJURY; REVIEW; TRANSPLANTATION; UNFOLDED PROTEIN RESPONSE; ANIMAL; GRAFT REJECTION; INFLAMMATION; NECROSIS; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY;

ANIMALS; ENDOPLASMIC RETICULUM STRESS; GRAFT REJECTION; HUMANS; INFLAMMATION; NECROSIS; ORGAN TRANSPLANTATION;

EID: 84983425576     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13963     Document Type: Review

References (400)

1. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211–217.
2. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991–1045.
3. Land W. Allograft injury mediated by reactive oxygen species: From conserved proteins of Drosophila to acute and chronic rejection of human transplants—Part III: Interaction of (oxidative) stress-induced heat shock proteins with Toll-like receptor-bearing cells of innate immunity and its consequences for the development of acute and chronic allograft rejection. Transplant Rev (Orlando) 2003; 17: 67–86.
4. Seong SY, Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469–478.
5. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516–521.
6. Chen CJ, Shi Y, Hearn A, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006; 116: 2262–2271.
7. Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007; 81: 1–5.
8. Rubartelli A, Lotze MT. Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2007; 28: 429–436.
9. Land WG. Emerging role of innate immunity in organ transplantation, part II: Potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells. Transplant Rev (Orlando) 2012; 26: 73–87.
10. Gallo PM, Gallucci S. The dendritic cell response to classic, emerging, and homeostatic danger signals: Implications for autoimmunity. Front Immunol 2013; 4: 138.
11. Land W. Postischemic reperfusion injury to allografts—a case for “innate immunity”? Eur Surg Res 2002; 34: 160–169.
12. Land W. Allograft injury mediated by reactive oxygen species: From conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part I: Demonstration of reactive oxygen species in reperfused allografts and their role in the initiation of innate immunity. Transplant Rev (Orlando) 2002; 16: 192–204.
13. Land W. Allograft injury mediated by reactive oxygen species: From conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part II: Role of reactive oxygen species in the induction of the heat shock response as a regulator of innate immunity. Transplant Rev 2003; 17: 31–44.
14. Land WG. Ageing and immunosuppression in kidney transplantation. Exp Clin Transplant 2004; 2: 229–237.
15. Land WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005; 79: 505–514.
16. Land WG. Innate Alloimmunity, Part 2. Innate Immunity and Rejection. Ankara-Lengerich: Başkent University-Pabst Science Publishers; 2011.
17. Wood KJ, Goto R. Mechanisms of rejection: Current perspectives. Transplantation 2012; 93: 1–10.
18. Danobeitia JS, Sperger JM, Hanson MS, et al. Early activation of the inflammatory response in the liver of brain-dead non-human primates. J Surg Res 2012; 176: 639–648.
19. Land WG. Chronic allograft dysfunction: A model disorder of innate immunity. Biomed J 2013; 36: 209–228.
20. Farrar CA, Kupiec-Weglinski JW, Sacks SH. The innate immune system and transplantation. Cold Spring Harb Perspect Med 2013; 3: a015479.
21. Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant 2013; 13: 2797–2804.
22. Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation—from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10: 79–89.
23. Denecke C, Tullius SG. Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney. Prog Urol 2014; 24(Suppl 1): S13–S19.
24. Dziodzio T, Biebl M, Pratschke J. Impact of brain death on ischemia/reperfusion injury in liver transplantation. Curr Opin Organ Transplant 2014; 19: 108–114.
25. Venner JM, Famulski KS, Badr D, Hidalgo LG, Chang J, Halloran PF. Molecular landscape of T cell-mediated rejection in human kidney transplants: Prominence of CTLA4 and PD ligands. Am J Transplant 2014; 14: 2565–2576.
26. Mori DN, Kreisel D, Fullerton JN, Gilroy DW, Goldstein DR. Inflammatory triggers of acute rejection of organ allografts. Immunol Rev 2014; 258: 132–144.
27. Abrahimi P, Liu R, Pober JS. Blood vessels in allotransplantation. Am J Transplant 2015; 15: 1748–1754.
28. Podestà MA, Cucchiari D, Ponticelli C. The diverging roles of dendritic cells in kidney allotransplantation. Transplant Rev (Orlando) 2015; 29: 114–120.
29. Otterbein LE, Fan Z, Koulmanda M, Thronley T, Strom TB. Innate immunity for better or worse govern the allograft response. Curr Opin Organ Transplant 2015; 20: 8–12.
30. Hu Q, Wood CR, Cimen S, Venkatachalam AB, Alwayn IP. Mitochondrial damage-associated molecular patterns (MTDs) are released during hepatic ischemia reperfusion and induce inflammatory responses. PLoS ONE 2015; 10: e0140105.
31. Land WG, Agostinis P, Gasser S, Garg AD, Linkermann A. DAMP-induced allograft and tumor rejection: the circle is closing. Am J Transplant. In press.
32. Pratschke J, Wilhelm MJ, Laskowski I, et al. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001; 12: 2474–2481.
33. Kosieradzki M, Kuczynska J, Piwowarska J, et al. Prognostic significance of free radicals: Mediated injury occurring in the kidney donor. Transplantation 2003; 75: 1221–1227.
34. Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006; 6: 2903–2911.
35. Stiegler P, Sereinigg M, Puntschart A, et al. Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD). J Transl Med 2013; 11: 244.
36. Leber B, Stadlbauer V, Stiegler P, et al. Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors. Transl Res 2012; 159: 487–496.
37. Morariu AM, Schuurs TA, Leuvenink HG, van Oeveren W, Rakhorst G, Ploeg RJ. Early events in kidney donation: Progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant 2008; 8: 933–941.
38. Marasco SF, Sheeran FL, Chaudhuri K, Vale M, Bailey M, Pepe S. Molecular markers of programmed cell death in donor hearts before transplantation. J Heart Lung Transplant 2014; 33: 185–193.
39. Cao S, Yan B, Lu Y, et al. C/EBP homologous protein-mediated endoplasmic reticulum stress-related renal apoptosis is involved in rats with brain death. Transplant Proc 2015; 47: 354–358.
40. Birks EJ, Yacoub MH, Burton PS, et al. Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation 2000; 70: 1498–1506.
41. Stoica SC, Satchithananda DK, Atkinson C, Charman S, Goddard M, Large SR. Heat shock protein, inducible nitric oxide synthase and apoptotic markers in the acute phase of human cardiac transplantation. Eur J Cardiothorac Surg 2003; 24: 932–939.
42. Pérez López S, Vázquez Moreno N, Escudero Augusto D, et al. A molecular approach to apoptosis in the human heart during brain death. Transplantation 2008; 86: 977–982.
43. Secher N, Soendergaard P, Ravlo K, et al. No effect of remote ischaemic conditioning on inflammation in a porcine kidney transplantation model. Transpl Immunol 2014; 31: 98–104.
44. Li S, Loganathan S, Korkmaz S, et al. Transplantation of donor hearts after circulatory or brain death in a rat model. J Surg Res 2015; 195: 315–324.
45. Arbogast H, Arbogast S, Fertmann J, et al. Expression of heat shock proteins in cadaveric human renal allografts—A role in activation of innate immunity? Transplantation 2002; 74: 266.
46. Krüger B, Krick S, Dhillon N, et al. Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390–3395.
47. Saat TC, Susa D, Kok NF, et al. Inflammatory genes in rat livers from cardiac- and brain death donors. J Surg Res 2015; 198: 217–227.
48. Rostron AJ, Cork DM, Avlonitis VS, Fisher AJ, Dark JH, Kirby JA. Contribution of toll-like receptor activation to lung damage after donor brain death. Transplantation 2010; 90: 732–739.
49. Chen L, Xu D, Gao Y, et al. Effect of donor JNK signal transduction inhibition on transplant outcome in brain dead rat model. Inflammation 2012; 35: 122–129.
50. Damman J, Daha MR, van Son WJ, Leuvenink HG, Ploeg RJ, Seelen MA. Crosstalk between complement and toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant 2011; 11: 660–669.
51. Takada M, Nadeau KC, Hancock WW, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65: 1533–1542.
52. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405–410.
53. Velásquez-Lopera MM, Correa LA, García LF. Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes. Clin Exp Immunol 2008; 154: 107–114.
54. Mittag D, Proietto AI, Loudovaris T, et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol 2011; 186: 6207–6217.
55. Saat TC, van den Akker EK, IJzermans JN, Dor FJ, de Bruin RW. Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: Lost in translation? J Transl Med 2016; 14: 20.
56. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Transplant Rev 1996; 10: 108–127 and 236–253.
57. Fertmann J, Arbogast H, Hoffmann J, Land W. Generation of hydroxyl radical is increased after reperfusion of human cadaveric renal allografts. Transplantation 2002; 74: 393.
58. Land WG. Emerging role of innate immunity in organ transplantation: Part I: Evolution of innate immunity and oxidative allograft injury. Transplant Rev (Orlando) 2012; 26: 60–72.
59. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552: 335–344.
60. Dröse S, Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J Biol Chem 2008; 283: 21649–21654.
61. Baudry N, Laemmel E, Vicaut E. In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: Involvement of xanthine oxidase and mitochondria. Am J Physiol Heart Circ Physiol 2008; 294: H821–H828.
62. Chong SJ, Low IC, Pervaiz S. Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS regulator. Mitochondrion 2014; 19 PtA: 39–48.
63. Chandel NS. Mitochondrial complex III: An essential component of universal oxygen sensing machinery? Respir Physiol Neurobiol 2010; 174: 175–181.
64. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev 2004; 36: 363–375.
65. Battelli MG, Bolognesi A, Polito L. Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme. Biochim Biophys Acta 2014; 1842: 1502–1517.
66. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181–190.
67. Sasaki M, Joh T. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr 2007; 40: 1–12.
68. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87: 245–313.
69. Rivera J, Sobey CG, Walduck AK, Drummond GR. Nox isoforms in vascular pathophysiology: Insights from transgenic and knockout mouse models. Redox Rep 2010; 15: 50–63.
70. Montezano AC, Touyz RM. Reactive oxygen species and endothelial function—Role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 2012; 110: 87–94.
71. Angelos MG, Kutala VK, Torres CA, et al. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol Heart Circ Physiol 2006; 290: H341–H347.
72. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012; 298: 229–317.
73. Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: Mechanisms and significance. Annu Rev Physiol 2010; 72: 19–44.
74. Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 2015; 16: 689–697. Erratum in: Nat Immunol 2015; 16: 889.
75. Raedschelders K, Ansley DM, Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 2012; 133: 230–255.
76. Rosentreter D, Funken D, Reifart J, Mende K, Rentsch M, Khandoga A. RIP1-dependent programmed necrosis is negatively regulated by caspases during hepatic ischemia-reperfusion. Shock 2015; 44: 72–76.
77. Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol 2015; 6: 524–551.
78. Zhao H, Ning J, Lemaire A, et al. Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. Kidney Int 2015; 87: 738–748.
79. Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA 2014; 111: 16836–16841
80. Xie Y, Hou W, Song X, et al. Ferroptosis: Process and function. Cell Death Differ 2016; 23: 369–379.
81. Hofmans S, Vanden Berghe T, Devisscher L, et al. Novel ferroptosis inhibitors with improved potency and ADME properties. J Med Chem 2016; 59: 2041–2053.
82. Kuznetsov G, Bush KT, Zhang PL, Nigam SK. Perturbations in maturation of secretory proteins and their association with endoplasmic reticulum chaperones in a cell culture model for epithelial ischemia. Proc Natl Acad Sci USA 1996; 93: 8584–8589.
83. Toth A, Nickson P, Mandl A, Bannister ML, Toth K, Erhardt P. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets 2007; 7: 205–218.
84. Wang Y, Tian J, Qiao X, et al. Intermedin protects against renal ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress. BMC Nephrol 2015; 16: 169.
85. Liu J, Ren F, Cheng Q, et al. Endoplasmic reticulum stress modulates liver inflammatory immune response in the pathogenesis of liver ischemia and reperfusion injury. Transplantation 2012; 94: 211–217.
86. Sun Y, Pu LY, Lu L, Wang XH, Zhang F, Rao JH. N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury. World J Gastroenterol 2014; 20: 15289–15298.
87. Gao J, Jiang Z, Wang S, Zhou Y, Shi X, Feng M. ER-stress of Kupffer cells involved in the conversion of natural regulatory T cells to Th17 cells in liver ischemia-reperfusion injury. J Gastroenterol Hepatol 2015; doi: 10.1111/jgh.13163.
88. Hu R, Chen ZF, Yan J, et al. Endoplasmic reticulum stress of neutrophils is required for ischemia/reperfusion-induced acute lung injury. J Immunol 2015; 195: 4802–4809.
89. Khan MM, Yang WL, Wang P. Endoplasmic reticulum stress in sepsis. Shock 2015; 44: 294–304.
90. Cominacini L, Mozzini C, Garbin U, et al. Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. Free Radic Biol Med 2015; 88: 233–242.
91. Lee WS, Yoo WH, Chae HJ. ER stress and autophagy. Curr Mol Med 2015; 15: 735–745.
92. Pyo JO, Nah J, Jung YK. Molecules and their functions in autophagy. Exp Mol Med 2012; 44: 73–80.
93. Thapalia BA, Zhou Z, Lin X. Autophagy, a process within reperfusion injury: An update. Int J Clin Exp Pathol 2014; 7: 8322–8341.
94. Li L, Tan J, Miao Y, Lei P, Zhang Q. ROS and autophagy: Interactions and molecular regulatory mechanisms. Cell Mol Neurobiol 2015; 35: 615–621.
95. Decuypere JP, Ceulemans LJ, Agostinis P, et al. Autophagy and the kidney: Implications for ischemia-reperfusion injury and therapy. Am J Kidney Dis 2015; 66: 699–709.
96. McDonald B, Pittman K, Menezes GB, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010; 330: 362–366.
97. Chandrika BB, Yang C, Ou Y, et al. Endoplasmic reticulum stress-induced autophagy provides cytoprotection from chemical hypoxia and oxidant injury and ameliorates renal ischemia-reperfusion injury. PLoS ONE 2015; 10: e0140025.
98. Toko H, Takahashi H, Kayama Y, et al. ATF6 is important under both pathological and physiological states in the heart. J Mol Cell Cardiol 2010; 49: 113–120.
99. Ling H, Chen H, Wei M, Meng X, Yu Y, Xie K. The effect of autophagy on inflammation cytokines in renal ischemia/reperfusion injury. Inflammation 2016; 39: 347–356.
100. Alnasser HA, Guan Q, Zhang F, Gleave ME, Nguan CY, Du C. Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells. Am J Physiol Renal Physiol 2016; 310: F160–F173.
101. Matsui Y, Kyoi S, Takagi H, et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008; 4: 409–415.
102. Fang B, Li XQ, Bao NR, et al. Role of autophagy in the bimodal stage after spinal cord ischemia reperfusion injury in rats. Neuroscience 2016; 328: 107–116.
103. Yan S, Sorrell M, Berman Z. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress. Cell Mol Life Sci 2014; 71: 3951–3967.
104. Ma Z, Wei Q, Dong G, Huo Y, Dong Z. DNA damage response in renal ischemia-reperfusion and ATP-depletion injury of renal tubular cells. Biochim Biophys Acta 2014; 1842: 1088–1096.
105. Fujino T, Muhib S, Sato N, Hasebe N. Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and down-regulates GSK-3beta expression after ischemia-reperfusion injury. Am J Physiol Renal Physiol 2013; 305: F1617–F1627.
106. Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: Protective role of a p53 inhibitor. J Am Soc Nephrol 2003; 14: 128–138.
107. Yoshida T, Shimizu A, Masuda Y, et al. Caspase-3-independent internucleosomal DNA fragmentation in ischemic acute kidney injury. Nephron Exp Nephrol 2012; 120: e103–e113.
108. Schumer M, Colombel MC, Sawczuk IS, et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992; 140: 831–838.
109. Liu PK, Hsu CY, Dizdaroglu M, et al. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J Neurosci 1996; 16: 6795–6806.
110. Cordis GA, Bagchi D, Riedel W, Stohs SJ, Das DK. Implication of DNA damage during reperfusion of ischemic myocardium. Ann NY Acad Sci 1996; 793: 427–430.
111. Cui J, Holmes EH, Greene TG, Liu PK. Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J 2000; 14: 955–967.
112. Shukla PC, Singh KK, Quan A, et al. BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun 2011; 2: 593.
113. Pardo M, Budick-Harmelin N, Tirosh B, Tirosh O. Antioxidant defense in hepatic ischemia-reperfusion injury is regulated by damage-associated molecular pattern signal molecules. Free Radic Biol Med 2008; 45: 1073–1083.
114. Iyer SS, Pulskens WP, Sadler JJ, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009; 106: 20388–20393.
115. Elliott MR, Chekeni FB, Trampont PC, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282–286.
116. Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15: 1170–1178.
117. Garg AD, Krysko DV, Verfaillie T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012; 31: 1062–1079.
118. Garg AD, Dudek AM, Ferreira GB, et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 2013; 9: 1292–1307.
119. Idzko M, Ferrari D, Eltzschig HK. Nucleotide signalling during inflammation. Nature 2014; 509: 310–317.
120. Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev 2015; 265: 35–52.
121. Yaron JR, Gangaraju S, Rao MY, et al. K(+) regulates Ca(2+) to drive inflammasome signaling: Dynamic visualization of ion flux in live cells. Cell Death Dis 2015; 6: e1954.
122. Di Virgilio F, Vuerich M. Purinergic signaling in the immune system. Auton Neurosci 2015; 191: 117–123.
123. Babelova A, Moreth K, Tsalastra-Greul W, et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009; 284: 24035–24048.
124. Schaefer L. Extracellular matrix molecules: Endogenous danger signals as new drug targets in kidney diseases. Curr Opin Pharmacol 2010; 10: 185–190.
125. Moreth K, Frey H, Hubo M, et al. Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol 2014; 35: 143–151.
126. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123: 321–334.
127. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54–61.
128. Kang JS, Dervan PB. A sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphoma. Q Rev Biophys 2015; 48: 453–464.
129. Raghavan M, Wijeyesakere SJ, Peters LR, Del Cid N. Calreticulin in the immune system: Ins and outs. Trends Immunol 2013; 34: 13–21.
130. Xia JG, Xu FF, Qu Y, Song DG, Shen H, Liu XH. Atorvastatin post-conditioning attenuates myocardial ischemia reperfusion injury via inhibiting endoplasmic reticulum stress-related apoptosis. Shock 2014; 42: 365–371.
131. Li Y, Zeng X, He L, Yuan H. Dendritic cell activation and maturation induced by recombinant calreticulin fragment 39-272. Int J Clin Exp Med 2015; 8: 7288–7296.
132. Bergler T, Hoffmann U, Bergler E, et al. Toll-like receptor 4 in experimental kidney transplantation: Early mediator of endogenous danger signals. Nephron Exp Nephrol 2012; 121: e59–e70.
133. Julier Z, Martino MM, de Titta A, Jeanbart L, Hubbell JA. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine. Sci Rep 2015; 5: 8569.
134. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: Relevance for tumor response. Cancer Res 2005; 65: 1018–1026.
135. Asea A. Heat shock proteins and toll-like receptors. Handb Exp Pharmacol 2008; 183: 111–127.
136. Garg AD, Nowis D, Golab J, Agostinis P. Photodynamic therapy: Illuminating the road from cell death towards anti-tumour immunity. Apoptosis 2010; 15: 1050–1071.
137. Suzuki S, Kulkarni AB. Extracellular heat shock protein HSP90 beta secreted by MG63 osteosarcoma cells inhibits activation of latent TGF-beta1. Biochem Biophys Res Commun 2010; 398: 525–531.
138. Cirone M, Di Renzo L, Lotti LV, et al. Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91. PLoS ONE 2012; 7: e31732.
139. Zunino B, Rubio-Patino C, Villa E, et al. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90. Oncogene 2016; 35: 261–268.
140. Land WG. Role of heat shock protein 70 in innate alloimmunity. Front Immunol 2012; 2: 89.
141. Miyake Y, Yamasaki S. Sensing necrotic cells. Adv Exp Med Biol 2012; 738: 144–152.
142. Timmermans K, Kox M, Scheffer GJ, Pickkers P. Danger in the intensive care unit: Damps in critically ill patients. Shock 2016; 45: 108–116.
143. Wu M, Wang H, Shi J, et al. Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: A novel adjuvant. Hum Vaccin Immunother 2014; 10: 3711–3721.
144. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191–195.
145. Semino C, Angelini G, Poggi A, Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005; 106: 609–616.
146. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050–1059.
147. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, Thorburn A. Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 2009; 16: 175–183.
148. Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 2011; 14: 1315–1335.
149. Tsung A, Tohme S, Billiar TR. High-mobility group box-1 in sterile inflammation. J Intern Med 2014; 276: 425–443.
150. Vénéreau E, Ceriotti C, Bianchi ME. DAMPs from cell death to new life. Front Immunol 2015; 6: 422.
151. Zhang J, Wang H, Xiao Q, et al. Hyaluronic acid fragments evoke Kupffer cells via TLR4 signaling pathway. Sci China C Life Sci 2009; 52: 147–154.
152. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011; 91: 221–264.
153. Yamasaki K, Muto J, Taylor KR, et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009; 284: 12762–12771.
154. Todd JL, Wang X, Sugimoto S, et al. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. Am J Respir Crit Care Med 2014; 189: 556–566.
155. Jung YJ, Lee AS, Nguyen-Thanh T, et al. Hyaluronan-induced VEGF-C promotes fibrosis-induced lymphangiogenesis via Toll-like receptor 4-dependent signal pathway. Biochem Biophys Res Commun 2015; 466: 339–345.
156. Colombaro V, Jadot I, Declèves AE, et al. Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis. Kidney Int 2015; 88: 61–71.
157. Watson NF, Spendlove I, Madjd Z, et al. Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int J Cancer 2006; 118: 1445–1452.
158. He Y, Li YP, Li SF, Long D. Effect of hypoxia/reoxygenation (H/R) on expression of MICA and MICB in human hepatocytes. Sichuan Da Xue Xue Bao Yi Xue Ban 2005; 36: 157–160.
159. Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 291: L222–L231.
160. Feng L, Cheng F, Ye Z, et al. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney. Transplant Proc 2006; 38: 2195–2198.
161. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 2013; 31: 413–441.
162. Marcus A, Gowen BG, Thompson TW, et al. Recognition of tumors by the innate immune system and natural killer cells. Adv Immunol 2014; 122: 91–128.
163. Suárez-Álvarez B, Fernández-Sánchez A, López-Vázquez A, Coto E, Ortega F, López-Larrea C. NKG2D and its ligands: Active factors in the outcome of solid organ transplantation? Kidney Int Suppl 2011; 1: 52–57.
164. Fionda C, Soriani A, Zingoni A, Santoni A, Cippitelli M. NKG2D and DNAM-1 ligands: Molecular targets for NK cell-mediated immunotherapeutic intervention in multiple myeloma. Biomed Res Int 2015; 2015: 178698.
165. Carapito R, Bahram S. Genetics, genomics, and evolutionary biology of NKG2D ligands. Immunol Rev 2015; 267: 88–116.
166. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005; 11: 4145–4151.
167. Peter C, Wesselborg S, Lauber K. Role of attraction and danger signals in the uptake of apoptotic and necrotic cells and its immunological outcome. In: Krysko DV, Vandenabeele P, editors. Phagocytosis of Dying Cells. Berlin: Springer Science + Business Media B.V., 2009; p. 63–101.
168. Kingsbury SR, Conaghan PG, McDermott MF. The role of the NLRP3 inflammasome in gout. J Inflamm Res 2011; 4: 39–49.
169. Rabadi MM, Kuo MC, Ghaly T, et al. Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Renal Physiol 2012; 302: F730–F741.
170. Zheng SC, Zhu XX, Xue Y, et al. Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes. J Inflamm (Lond) 2015; 12: 30.
171. Zhang M, Alicot EM, Chiu I, et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 2006; 203: 141–152.
172. Lee H, Green DJ, Lai L, et al. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol Immunol 2010; 47: 972–981.
173. Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 2004; 75: 995–1000.
174. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542–12550.
175. Lamphier MS, Sirois CM, Verma A, Golenbock DT, Latz E. TLR9 and the recognition of self and non-self nucleic acids. Ann N Y Acad Sci 2006; 1082: 31–43.
176. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104–107.
177. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, DeMatteo RP. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010; 51: 621–632.
178. Krysko DV, Agostinis P, Krysko O, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011; 32: 157–164.
179. Galluzzi L, Kepp O, Kroemer G. Mitochondria: Master regulators of danger signalling. Nat Rev Mol Cell Biol 2012; 13: 780–788.
180. Jounai N, Kobiyama K, Takeshita F, Ishii KJ. Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front Cell Infect Microbiol 2013; 2: 168.
181. Brencicova E, Diebold SS. Nucleic acids and endosomal pattern recognition: How to tell friend from foe? Front Cell Infect Microbiol 2013; 3: 37.
182. Nakahira K, Hisata S, Choi AM. The roles of mitochondrial damage-associated molecular patterns in diseases. Antioxid Redox Signal 2015; 23: 1329–1350.
183. Wenceslau CF, McCarthy CG, Szasz T, Spitler K, Goulopoulou S, Webb RC; Working Group on DAMPs in Cardiovascular Disease. Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J 2014; 35: 1172–1177.
184. Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014; 32: 461–488.
185. Sharma S, Fitzgerald KA, Cancro MP, Marshak-Rothstein A. Nucleic acid-sensing receptors: Rheostats of autoimmunity and autoinflammation. J Immunol 2015; 195: 3507–3512.
186. Xiao TS. The nucleic acid-sensing inflammasomes. Immunol Rev 2015; 265: 103–111.
187. Woo SR, Fuertes MB, Corrales L, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 2014; 41: 830–842.
188. Ma F, Li B, Liu SY, et al. Positive feedback regulation of type I IFN production by the IFN-inducible DNA sensor cGAS. J Immunol 2015; 194: 1545–1554.
189. He S, Mao X, Sun H, Shirakawa T, Zhang H, Wang X. Potential therapeutic targets in the process of nucleic acid recognition: Opportunities and challenges. Trends Pharmacol Sci 2015; 36: 51–64.
190. Lan YY, Londoño D, Bouley R, Rooney MS, Hacohen N. Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. Cell Rep 2014; 9: 180–192.
191. Tsuruya K, Furuichi M, Tominaga Y, et al. Accumulation of 8-oxoguanine in the cellular DNA and the alteration of the OGG1 expression during ischemia-reperfusion injury in the rat kidney. DNA Repair (Amst) 2003; 2: 211–229.
192. Moghaddam AE, Gartlan KH, Kong L, Sattentau QJ. Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress. J Immunol 2011; 187: 1626–1633.
193. Miller YI, Choi SH, Wiesner P, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011; 108: 235–248.
194. Weismann D, Binder CJ. The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta 2012; 1818: 2465–2475.
195. Vandenberk L, Garg AD, Verschuere T, et al. Irradiation of necrotic cancer cells employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology 2016; 5: e1083669.
196. Tsiantoulas D, Perkmann T, Afonyushkin T, et al. Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J Lipid Res 2015; 56: 440–448.
197. Matt U, Sharif O, Martins R, Knapp S. Accumulating evidence for a role of oxidized phospholipids in infectious diseases. Cell Mol Life Sci 2015; 72: 1059–1071.
198. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001; 69: 986–994.
199. Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S. Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 2004; 21: 72–76.
200. Donato R. RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins. Curr Mol Med 2007; 7: 711–724.
201. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007; 81: 28–37.
202. Schiopu A, Cotoi OS. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Inflamm 2013; 2013: 828354.
203. Rohde D, Schön C, Boerries M, et al. S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4. EMBO Mol Med 2014; 6: 778–794.
204. Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS. Transcriptional regulation of the endogenous danger signal tenascin-C: A novel autocrine loop in inflammation. J Immunol 2010; 184: 2655–2662.
205. Giblin SP, Midwood KS. Tenascin-C: Form versus function. Cell Adh Migr 2015; 9: 48–82.
206. Huergo-Zapico L, Acebes-Huerta A, López-Soto A, Villa-Álvarez M, Gonzalez-Rodriguez AP, Gonzalez S. Molecular bases for the regulation of NKG2D ligands in cancer. Front Immunol 2014; 5: 106.
207. López-Soto A, Huergo-Zapico L, Acebes-Huerta A, Villa-Alvarez M, Gonzalez S. NKG2D signaling in cancer immunosurveillance. Int J Cancer 2015; 136: 1741–1750.
208. Chen GE, Wu H, Ma J, Chadban SJ, Sharland A. Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells. Nephrol Dial Transplant 2011; 26: 3873–3881.
209. Huang H, Evankovich J, Yan W, et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011; 54: 999–1008.
210. Garg A, Galluzzi L, Apetoh L, et al. Molecular and translational classifications of DAMPs in immunogenic cell death. Front Immunol 2015; 6: 588.
211. Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: Awaiting a clinical response. J Clin Invest 2012; 122: 2711–2719.
212. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 2010; 11: 373–384.
213. Lee EJ, Park JH. Receptor for advanced glycation endproducts (RAGE), its ligands, and soluble RAGE: Potential biomarkers for diagnosis and therapeutic targets for human renal diseases. Genomics Inform 2013; 11: 224–229.
214. Zhong Y, Kinio A, Saleh M. Functions of NOD-like receptors in human diseases. Front Immunol 2013; 4: 333.
215. Drummond RA, Brown GD. Signalling C-type lectins in antimicrobial immunity. PLoS Pathog 2013; 9: e1003417.
216. Alessandra P, Sergio C. NOD-like receptors: A tail from plants to mammals through invertebrates. Curr Protein Pept Sci 2016. [Epub ahead of print].
217. Sohn J, Hur S. Filament assemblies in foreign nucleic acid sensors. Curr Opin Struct Biol 2016; 37: 134–144.
218. Unterholzner L. The interferon response to intracellular DNA: Why so many receptors? Immunobiology 2013; 218: 1312–1321.
219. Ratsimandresy RA, Dorfleutner A, Stehlik C. An update on PYRIN domain-containing pattern recognition receptors: From immunity to pathology. Front Immunol 2013; 4: 440.
220. Hansen JD, Vojtech LN, Laing KJ. Sensing disease and danger: A survey of vertebrate PRRs and their origins. Dev Comp Immunol 2011; 35: 886–897.
221. Lee SM, Hutchinson M, Saint DA. The role of Toll-like receptor 4 (TLR4) in cardiac ischaemic-reperfusion injury, cardioprotection and preconditioning. Clin Exp Pharmacol Physiol 2016; 43: 864–871.
222. Zhou JQ, Qiu T, Zhang L, et al. Allopurinol preconditioning attenuates renal ischemia/reperfusion injury by inhibiting HMGB1 expression in a rat model. Acta Cir Bras 2016; 31: 176–182.
223. Mersmann J, Iskandar F, Latsch K, et al. Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent. Mediators Inflamm 2013; 2013: 174168.
224. Sugihara M, Sadamori H, Nishibori M, et al. Anti-high mobility group box 1 monoclonal antibody improves ischemia/reperfusion injury and mode of liver regeneration after partial hepatectomy. Am J Surg 2016; 211: 179–188.
225. Thierry A, Giraud S, Robin A, et al. The alarmin concept applied to human renal transplantation: Evidence for a differential implication of HMGB1 and IL-33. PLoS ONE 2014; 9: e88742.
226. Yu Y, Tang D, Kang R. Oxidative stress-mediated HMGB1 biology. Front Physiol 2015; 6: 93.
227. Faybik P, Wachauer D, Hetz H, et al. Perioperative kinetics of heat shock protein 60 in serum during orthotopic liver transplantation. Transplant Proc 2004; 36: 1469–1472.
228. Pockley AG, Muthana M. Heat shock proteins and allograft rejection. Contrib Nephrol 2005; 148: 122–134.
229. Bidmon B, Kratochwill K, Rusai K, et al. Increased immunogenicity is an integral part of the heat shock response following renal ischemia. Cell Stress Chaperones 2012; 17: 385–397.
230. Zhang S, Wu D, Wang J, et al. Stress protein expression in early phase spinal cord ischemia/reperfusion injury. Neural Regen Res 2013; 8: 2225–2235.
231. Guo Q, Du X, Zhao Y, Zhang D, Yue L, Wang Z. Ischemic postconditioning prevents renal ischemia reperfusion injury through the induction of heat shock proteins in rats. Mol Med Rep 2014; 10: 2875–2881.
232. O'Neill S, Harrison EM, Ross JA, Wigmore SJ, Hughes J. Heat-shock proteins and acute ischaemic kidney injury. Nephron Exp Nephrol 2014; 126: 167–174.
233. Kamińska D, Kościelska-Kasprzak K, Drulis-Fajdasz D, et al. Kidney ischemic injury genes expressed after donor brain death are predictive for the outcome of kidney transplantation. Transplant Proc 2011; 43: 2891–2894.
234. Nano R, Racanicchi L, Melzi R, et al. Human pancreatic islet preparations release HMGB1: (ir)relevance forgraft engraftment. Cell Transplant 2013; 22: 2175–2186.
235. Xystrakis E, Yuksel M, Lin F, et al. Impact of donation mode on the proportion and function of T lymphocytes in the liver. PLoS ONE 2015; 10: e0139791.
236. van Dullemen LF, Bos EM, Schuurs TA, et al. Brain death induces renal expression of hemeoxygenase-1 and heat shock protein 70. J Transl Med 2013; 11: 22.
237. Kono H, Kimura Y, Latz E. Inflammasome activation in response to dead cells and their metabolites. Curr Opin Immunol 2014; 30: 91–98.
238. Vanaja SK, Rathinam VA, Fitzgerald KA. Mechanisms of inflammasome activation: Recent advances and novel insights. Trends Cell Biol 2015; 25: 308–315.
239. Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev 2015; 265: 6–21.
240. Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 2014; 5: 352.
241. Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol 2016; 13: 148–159.
242. Carta S, Penco F, Lavieri R, et al. Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance. Proc Natl Acad Sci USA 2015; 112: 2835–2840.
243. Santos CX, Tanaka LY, Wosniak J, Laurindo FR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: Roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 2009; 11: 2409–2427.
244. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136–140.
245. Kim S, Joe Y, Jeong SO, et al. Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways. Innate Immun 2014; 20: 799–815.
246. Bronner DN, Abuaita BH, Chen X, et al. Endoplasmic reticulum stress activates the inflammasome via NLRP3- and caspase-2-driven mitochondrial damage. Immunity 2015; 43: 451–462.
247. Jakobs C, Perner S, Hornung V. AIM2 drives joint inflammation in a self-DNA triggered model of chronic polyarthritis. PLoS ONE 2015; 10: e0131702.
248. Man SM, Karki R, Kanneganti TD. AIM2 inflammasome in infection, cancer and autoimmunity: Role in DNA sensing, inflammation and innate immunity. Eur J Immunol 2016; 46: 269–280.
249. Messmer D, Yang H, Telusma G, et al. High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004; 173: 307–313.
250. Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol 2005; 35: 2184–2190.
251. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 2007; 81: 84–91.
252. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007; 81: 59–66.
253. Manfredi AA, Capobianco A, Bianchi ME, Rovere-Querini P. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit Rev Immunol 2009; 29: 69–86.
254. Li G, Liang X, Lotze MT. HMGB1: The central cytokine for all lymphoid cells. Front Immunol 2013; 4: 68.
255. Zhu XM, Yao YM, Liang HP, et al. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J Interferon Cytokine Res 2009; 29: 677–686.
256. Nace G, Evankovich J, Eid R, Tsung A. Dendritic cells and damage-associated molecular patterns: Endogenous danger signals linking innate and adaptive immunity. J Innate Immun 2012; 4: 6–15.
257. Cappelletti M, Presicce P, Calcaterra F, Mavilio D, Della BS. Bright expression of CD91 identifies highly activated human dendritic cells that can be expanded by defensins. Immunology 2015; 144: 661–667.
258. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011; 243: 206–214.
259. Zhang K, Gao B, Wang Y, et al. Serum uric acid and renal transplantation outcomes: At least 3-year post-transplant retrospective multivariate analysis. PLoS ONE 2015; 10: e0133834.
260. Idzko M, Ferrari D, Riegel AK, Eltzschig HK. Extracellular nucleotide and nucleoside signaling in vascular and blood disease. Blood 2014; 124: 1029–1037.
261. Gombault A, Baron L, Couillin I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Front Immunol 2013; 3: 414.
262. Wanderer AA. Rationale and timeliness for IL-1beta-targeted therapy to reduce allogeneic organ injury at procurement and to diminish risk of rejection after transplantation. Clin Transplant 2010; 24: 307–311.
263. Tong Y, Ding ZH, Zhan FX, et al. The NLRP3 inflammasome and stroke. Int J Clin Exp Med 2015; 8: 4787–4794.
264. Sandanger Ø, Ranheim T, Vinge LE, et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 2013; 99: 164–174.
265. Liu Y, Lian K, Zhang L, et al. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol 2014; 109: 415.
266. He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res 2015; 25: 1285–1298.
267. Moretta L, Montaldo E, Vacca P, et al. Human natural killer cells: Origin, receptors, function, and clinical applications. Int Arch Allergy Immunol 2014; 164: 253–264.
268. Lanier LL. NKG2D receptor and its ligands in host defense. Cancer Immunol Res 2015; 3: 575–582.
269. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994; 91: 6259–6263.
270. Bahram S, Mizuki N, Inoko H, Spies T. Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics 1996; 44: 80–81.
271. Radosavljevic M, Cuillerier B, Wilson MJ, et al. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 2002; 79: 114–123.
272. Ferlazzo G, Moretta L. Dendritic cell editing by natural killer cells. Crit Rev Oncog 2014; 19: 67–75.
273. Ferlazzo G, Morandi B. Cross-talks between natural killer cells and distinct subsets of dendritic cells. Front Immunol 2014; 5: 159.
274. Hadad U, Martinez O, Krams SM. NK cells after transplantation: Friend or foe. Immunol Res 2014; 58: 259–267.
275. Kohei N, Tanaka T, Tanabe K, et al. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts. Kidney Int 2016; 89: 1293–1306.
276. Luo L, Lu J, Wei L, et al. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 2010; 11: 91.
277. Wei L, Lu J, Feng L, et al. HIF-1alpha accumulation upregulates MICA and MICB expression on human cardiomyocytes and enhances NK cell cytotoxicity during hypoxia-reoxygenation. Life Sci 2010; 87: 111–119.
278. Quiroga I, Salio M, Koo DD, et al. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies. Transplantation 2006; 81: 1196–1203.
279. Zhang M, Carroll MC. Natural IgM-mediated innate autoimmunity: A new target for early intervention of ischemia-reperfusion injury. Expert Opin Biol Ther 2007; 7: 1575–1582.
280. Lutz HU, Binder CJ, Kaveri S. Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol 2009; 30: 43–51.
281. Shi T, Moulton VR, Lapchak PH, Deng GM, Dalle Lucca JJ, Tsokos GC. Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2009; 296: G339–G347.
282. Binder CJ. Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv Exp Med Biol 2012; 750: 2–13.
283. Elvington A, Atkinson C, Kulik L, et al. Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice. J Immunol 2012; 188: 1460–1468.
284. Bartolini Gritti B, Binder CJ. Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis. Hämostaseologie 2016; 36: 89–96.
285. Zhou W, Farrar CA, Abe K, et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 1363–1371.
286. Peng Q, Li K, Smyth LA, et al. C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol 2012; 23: 1474–1485.
287. Zhou W. The new face of anaphylatoxins in immune regulation. Immunobiology 2012; 217: 225–234.
288. Zaal A, Lissenberg-Thunnissen SN, van Schijndel G, Wouters D, van Ham SM, ten Brinke A. Crosstalk between Toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production. Immunobiology 2013; 218: 175–180.
289. Li K, Fazekasova H, Wang N, et al. Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 2012; 217: 65–73.
290. Zhu XM, Yao FH, Yao YM, Dong N, Yu Y, Sheng ZY. Endoplasmic reticulum stress and its regulator XBP-1 contributes to dendritic cell maturation and activation induced by high mobility group box-1 protein. Int J Biochem Cell Biol 2012; 44: 1097–1105.
291. Zheng Y, Yin G, Le V, et al. Hypericin-based photodynamic therapy induces a tumor-specific immune response and an effective DC-based cancer immunotherapy. Biochem Pharmacol 2014. [Epub ahead of print]
292. Luís A, Martins JD, Silva A, Ferreira I, Cruz MT, Neves BM. Oxidative stress-dependent activation of the eIF2α–ATF4 unfolded protein response branch by skin sensitizer 1-fluoro-2,4-dinitrobenzene modulates dendritic-like cell maturation and inflammatory status in a biphasic manner [corrected]. Free Radic Biol Med 2014; 77: 217–229.
293. Olagnier D, Peri S, Steel C, et al. Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. PLoS Pathog 2014; 10: e1004566.
294. Galluzzi L, Bravo-San Pedro JM, Vitale I, et al. Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015. Cell Death Differ 2015; 22: 58–73.
295. Hightower LE. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 1991; 66: 191–197.
296. Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: Degradation and reactivation of damaged proteins. Annu Rev Genet 1993; 27: 437–496.
297. Schlesinger MJ. Heat shock in vertebrate cells. Cell Stress Chaperones 1996; 1: 213–214.
298. Beere HM. “The stress of dying:” The role of heat shock proteins in the regulation of apoptosis. J Cell Sci 2004; 117: 2641–2651.
299. Westerheide SD, Morimoto RI. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 2005; 280: 33097–33100.
300. Kennedy D, Jäger R, Mosser DD, Samali A. Regulation of apoptosis by heat shock proteins. IUBMB Life 2014; 66: 327–338.
301. Mambula SS, Stevenson MA, Ogawa K, Calderwood SK. Mechanisms for Hsp70 secretion: Crossing membranes without a leader. Methods 2007; 43: 168–175.
302. Calderwood SK, Mambula SS, Gray PJ Jr. Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 2007; 1113: 28–39.
303. Campanella C, Bucchieri F, Merendino AM, et al. The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS ONE 2012; 7: e42008.
304. Merendino AM, Bucchieri F, Campanella C, et al. Hsp60 is actively secreted by human tumor cells. PLoS ONE 2010; 5: e9247.
305. Hayoun D, Kapp T, Edri-Brami M, et al. HSP60 is transported through the secretory pathway of 3-MCA-induced fibrosarcoma tumour cells and undergoes N-glycosylation. FEBS J 2012; 279: 2083–2095.
306. Kose S, Imamoto N. Nucleocytoplasmic transport under stress conditions and its role in HSP70 chaperone systems. Biochim Biophys Acta 2014; 1840: 2953–2960.
307. Zhu H, Fang X, Zhang D, et al. Membrane-bound heat shock proteins facilitate the uptake of dying cells and cross-presentation of cellular antigen. Apoptosis 2015; 21: 96–109.
308. Pirkkala L, Nykänen P, Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 2001; 15: 1118–1131.
309. Nishizawa J, Nakai A, Matsuda K, Komeda M, Ban T, Nagata K. Reactive oxygen species play an important role in the activation of heat shock factor 1 in ischemic-reperfused heart. Circulation 1999; 99: 934–941.
310. Jiang S, Tu K, Fu Q, et al. Multifaceted roles of HSF1 in cancer. Tumour Biol 2015; 36: 4923–4931.
311. Schilling D, Kühnel A, Tetzlaff F, Konrad S, Multhoff G. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells. Cancer Immunol Immunother 2015; 64: 599–608.
312. Mosser DD, Kotzbauer PT, Sarge KD, Morimoto RI. In vitro activation of heat shock transcription factor DNA-binding by calcium and biochemical conditions that affect protein conformation. Proc Natl Acad Sci USA 1990; 87: 3748–3752.
313. Balogh G, Horváth I, Nagy E, et al. The hyperfluidization of mammalian cell membranes acts as a signal to initiate the heat shock protein response. FEBS J 2005; 272: 6077–6086.
314. Bromberg Z, Goloubinoff P, Saidi Y, Weiss YG. The membrane-associated transient receptor potential vanilloid channel is the central heat shock receptor controlling the cellular heat shock response in epithelial cells. PLoS ONE 2013; 8: e57149.
315. Szöllősi AG, Oláh A, Tóth IB, et al. Transient receptor potential vanilloid-2 mediates the effects of transient heat shock on endocytosis of human monocyte-derived dendritic cells. FEBS Lett 2013; 587: 1440–1445.
316. Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74: 739–789.
317. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8: 519–529.
318. Wang Q, Groenendyk J, Michalak M. Glycoprotein quality control and endoplasmic reticulum stress. Molecules 2015; 20: 13689–13704.
319. Díaz-Villanueva JF, Díaz-Molina R, García-González V. Protein folding and mechanisms of proteostasis. Int J Mol Sci 2015; 16: 17193–17230.
320. Garg AD, Agostinis P. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. Photochem Photobiol Sci 2014; 13: 474–487.
321. van Vliet AR, Martin S, Garg AD, Agostinis P. The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond. Semin Cancer Biol 2015; 33: 74–85.
322. Rodvold JJ, Mahadevan NR, Zanetti M. Immune modulation by ER stress and inflammation in the tumor microenvironment. Cancer Lett 2015; 380: 227–236.
323. Dandekar A, Mendez R, Zhang K. Cross talk between ER stress, oxidative stress, and inflammation in health and disease. Methods Mol Biol 2015; 1292: 205–214.
324. Martinon F, Glimcher LH. Regulation of innate immunity by signaling pathways emerging from the endoplasmic reticulum. Curr Opin Immunol 2011; 23: 35–40.
325. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011; 13: 184–190.
326. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol 2012; 197: 857–867.
327. Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal 2014; 21: 396–413.
328. Hetz C, Chevet E, Oakes SA. Proteostasis control by the unfolded protein response. Nat Cell Biol 2015; 17: 829–838.
329. Finka A, Sharma SK, Goloubinoff P. Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70/HSP110 chaperones. Front Mol Biosci 2015; 2: 29.
330. Spiro RG, Zhu Q, Bhoyroo V, Söling HD. Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi. J Biol Chem 1996; 271: 11588–11594.
331. Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: New partners in redox signaling. Curr Pharm Des 2015; 21: 5951–5963.
332. Wiersma VR, Michalak M, Abdullah TM, Bremer E, Eggleton P. Mechanisms of translocation of ER chaperones to the cell surface and immunomodulatory roles in cancer and autoimmunity. Front Oncol 2015; 5: 7.
333. Panaretakis T, Joza N, Modjtahedi N, et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 2008; 15: 1499–1509.
334. Panaretakis T, Kepp O, Brockmeier U, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28: 578–590.
335. Satpute-Krishnan P, Ajinkya M, Bhat S, Itakura E, Hegde RS, Lippincott-Schwartz J. ER stress-induced clearance of misfolded GPI-anchored proteins via the secretory pathway. Cell 2014; 158: 522–533.
336. Lerner AG, Upton JP, Praveen PV, et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 2012; 16: 250–264.
337. Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016; 12: 1–222.
338. Zhang Q, Kang R, Zeh HJ 3rd, Lotze MT, Tang D. DAMPs and autophagy: Cellular adaptation to injury and unscheduled cell death. Autophagy 2013; 9: 451–458.
339. Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity 2013; 39: 211–227.
340. Bhattacharya A, Eissa NT. Autophagy as a stress response pathway in the immune system. Int Rev Immunol 2015; 34: 382–402.
341. Martins I, Wang Y, Michaud M, et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ 2014; 21: 79–91.
342. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99–163.
343. Galluzzi L, Morselli E, Kepp O, Kroemer G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim Biophys Acta 2009; 1787: 402–413.
344. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40: e331–e339.
345. Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107–120.
346. Halestrap AP, Richardson AP. The mitochondrial permeability transition: A current perspective on its identity and role in ischaemia/reperfusion injury. J Mol Cell Cardiol 2015; 78: 129–141.
347. Ayna G, Krysko DV, Kaczmarek A, Petrovski G, Vandenabeele P, Fésüs L. ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS ONE 2012; 7: e40069.
348. Garg AD, Dudek AM, Agostinis P. Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A. Cell Death Dis 2013; 4: e826.
349. Dixon SJ, Patel DN, Welsch M, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 2014; 3: e02523.
350. Weitzman MD, Weitzman JB. What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host Microbe 2014; 15: 283–294.
351. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 2011; 711: 193–201.
352. Ogrunc M, Di Micco R, Liontos M, et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ 2014; 21: 998–1012.
353. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014; 24: R453–R462.
354. Glebova K, Veiko N, Kostyuk S, Izhevskaya V, Baranova A. Oxidized extracellular DNA as a stress signal that may modify response to anticancer therapy. Cancer Lett 2015; 356: 22–33.
355. Weyemi U, Dupuy C. The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses. Mutat Res 2012; 751: 77–81.
356. Hegde ML, Mantha AK, Hazra TK, Bhakat KK, Mitra S, Szczesny B. Oxidative genome damage and its repair: Implications in aging and neurodegenerative diseases. Mech Ageing Dev 2012; 133: 157–168.
357. Hills SA, Diffley JF. DNA replication and oncogene-induced replicative stress. Curr Biol 2014; 24: R435–R444.
358. Dobbelstein M, Sørensen CS. Exploiting replicative stress to treat cancer. Nat Rev Drug Discov 2015; 14: 405–423.
359. Gaillard H, García-Muse T, Aguilera A. Replication stress and cancer. Nat Rev Cancer 2015; 15: 276–289.
360. Branzei D, Foiani M. Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol 2010; 11: 208–219.
361. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461: 1071–1078.
362. Ciccia A, Elledge SJ. The DNA damage response: Making it safe to play with knives. Mol Cell 2010; 40: 179–204.
363. Czarny P, Pawlowska E, Bialkowska-Warzecha J, Kaarniranta K, Blasiak J. Autophagy in DNA damage response. Int J Mol Sci 2015; 16: 2641–2662.
364. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12: 440–450.
365. Maréchal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol 2013; 5.
366. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39–85.
367. Härtlova A, Erttmann SF, Raffi FA, et al. DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. Immunity 2015; 42: 332–343.
368. Le Bert N, Lam AR, Ho SS, Shen YJ, Liu MM, Gasser S. STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression. Oncoimmunology 2014; 3: e29259.
369. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436: 1186–1190.
370. Lam AR, Le Bert N, Ho SS, et al. RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. Cancer Res 2014; 74: 2193–2203.
371. Soriani A, Zingoni A, Cerboni C, et al. ATM-ATR-dependent upregulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 2009; 113: 3503–3511.
372. He S, Wang L, Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100–1111.
373. Cho YS, Challa S, Moquin D, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137: 1112–1123.
374. Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332–336.
375. Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213–227.
376. Zhao J, Jitkaew S, Cai Z, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012; 109: 5322–5327.
377. Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 2015; 526: 666–671.
378. Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526: 660–665.
379. Desai J, Vr SK, Mulay SR, et al. Neutrophil extracellular trap formation can involve RIPK1-RIPK3-MLKL signalling. Eur J Immunol 2016; 46: 223–229.
380. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature 2015; 517: 311–320.
381. Taylor RC, Cullen SP, Martin SJ. Apoptosis: Controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231–241.
382. Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z. Regulated cell death in AKI. J Am Soc Nephrol 2014; 25: 2689–2701.
383. Khan KH, Blanco-Codesido M, Molife LR. Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev Oncol Hematol 2014; 90: 200–219.
384. Linkermann A, Green DR. Necroptosis. N Engl J Med 2014; 370: 455–465.
385. Belizário J, Vieira-Cordeiro L, Enns S. Necroptotic cell death signaling and execution pathway: Lessons from knockout mice. Mediators Inflamm 2015; 2015: 128076.
386. Tanzer MC, Tripaydonis A, Webb AI, et al. Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop. Biochem J 2015; 471: 255–265.
387. Lalaoui N, Lindqvist LM, Sandow JJ, Ekert PG. The molecular relationships between apoptosis, autophagy and necroptosis. Semin Cell Dev Biol 2015; 39: 63–69.
388. Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 2015; 14: 48.
389. Su Z, Yang Z, Xu Y, Chen Y, Yu Q. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget 2015; 6: 8474–8490.
390. Newton K. RIPK1 and RIPK3: Critical regulators of inflammation and cell death. Trends Cell Biol 2015; 25: 347–353.
391. Lawlor KE, Khan N, Mildenhall A, et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 2015; 6: 6282.
392. Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant 2015; 5: 52–67.
393. Wickman GR, Julian L, Mardilovich K, et al. Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs. Cell Death Differ 2013; 20: 1293–1305.
394. Rickard JA, O'Donnell JA, Evans JM, et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 2014; 157: 1175–1188.
395. Schiering C, Krausgruber T, Chomka A, et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014; 513: 564–568.
396. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209–223.
397. Ladoire S, Hannani D, Vetizou M, et al. Cell-death-associated molecular patterns as determinants of cancer immunogenicity. Antioxid Redox Signal 2014; 20: 1098–1116.
398. Linkermann A, Stockwell BR, Krautwald S, Anders HJ. Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat Rev Immunol 2014; 14: 759–767.
399. Mulay SR, Linkermann A, Anders HJ. Necroinflammation in kidney disease. J Am Soc Nephrol 2016; 27: 27–39.
400. Janssens S, Pulendran B, Lambrecht BN. Emerging functions of the unfolded protein response in immunity. Nat Immunol 2014; 15: 910–919.